Temoporfin is an investigational drug.
There have been 7 clinical trials for Temoporfin.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 1998.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Squamous Cell, and Bile Duct Neoplasms. The leading clinical trial sponsors are Biolitec Pharma Ltd., Roswell Park Cancer Institute, and University of Arkansas.